Abstract
A novel influenza A(H1N1)2009 variant with mildly reduced oseltamivir and zanamivir sensitivity has been detected in more than 10% of community specimens in Singapore and more than 30% of samples from northern Australia during the early months of 2011. The variant, which has also been detected in other regions of the Asia-Pacific, contains a S247N neuraminidase mutation. When combined with the H275Y mutation, as detected in an oseltamivir-treated patient, the dual S247N+H275Y mutant had extremely high oseltamivir resistance.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antiviral Agents / therapeutic use
-
Australia / epidemiology
-
Drug Resistance / genetics
-
Genetic Predisposition to Disease / epidemiology
-
Genetic Predisposition to Disease / genetics
-
Genetic Variation / genetics
-
Humans
-
Incidence
-
Influenza A Virus, H1N1 Subtype / genetics*
-
Influenza, Human / drug therapy
-
Influenza, Human / epidemiology*
-
Influenza, Human / genetics*
-
Neuraminidase / antagonists & inhibitors
-
Neuraminidase / genetics*
-
Oseltamivir / therapeutic use*
-
Polymorphism, Single Nucleotide / genetics*
-
Population Surveillance / methods
-
Risk Assessment
-
Risk Factors
-
Singapore / epidemiology
-
Zanamivir / therapeutic use*
Substances
-
Antiviral Agents
-
Oseltamivir
-
Neuraminidase
-
Zanamivir